Jihong Hu | Hypertension | Best Researcher AwardĀ 

šŸŽ“Current Position and Research Focus:

Dr. Hu holds a position at a respected institution where they continue to contribute significantly to the fields of preventive medicine and public health. Their ongoing research focuses on areas such as hypertension, cardiovascular risk assessment, and traditional Chinese medicine applications for chronic disease prevention. Through innovative studies and applied clinical work, Dr. Hu aims to enhance understanding of disease mechanisms and contribute to the development of preventive strategies in both Western and traditional Chinese medicine.

šŸ“šAcademic Background:

Dr. Hu began their academic journey at Ningxia Medical University, earning a masterā€™s degree in preventive medicine in 2000. Subsequently, they completed an undergraduate degree in the same field, graduating in 2003. Driven by a passion for epidemiology and health statistics, Dr. Hu went on to earn a doctorate from Peking Union Medical College in 2007. These degrees laid a solid foundation for a career devoted to advancing preventive medicine in both academic and clinical settings.

šŸ“Publications and Scientific Achievements:

Over the last five years, Dr. Hu has contributed numerous papers to prestigious journals, often as the first author or corresponding author. Notable publications include research on:

  • Salt sensitivity and hypertension, investigating how salt substitutes impact blood pressure across different age groups.
  • PD-L1 expression in colorectal cancer, where Dr. Huā€™s analysis provided insights into prognostic factors.
  • Gut microbiome research, exploring its association with diseases like obesity and hypertension.

These publications highlight Dr. Hu's versatility in addressing a wide range of health issues, often using meta-analyses to consolidate knowledge across studies.

šŸ”¬Ongoing Research Projects:

Dr. Hu actively participates in numerous research projects, often funded by prestigious bodies like the National Natural Science Foundation of China. Current projects include:

  • Internet+Chinese Medicine Integration: Investigating the role of Chinese medicine in preventing and controlling chronic diseases through technology.
  • Pediatric Intestinal Microecology: Examining how gut health affects respiratory infections in children.
  • Lumbar Disc Herniation Therapy: Standardizing Chinese medicine treatments for lumbar issues, focusing on Gansuā€™s regional medical practices.
  • Stroke and Traditional Medicine: Studying ischemic stroke through a traditional Chinese medicine perspective and assessing its diagnostic value.

These projects underscore Dr. Huā€™s dedication to combining traditional Chinese medicine with modern epidemiology, aiming to offer holistic health solutions.

šŸ”Research Interests:

Dr. Huā€™s research interests cover an impressive range within public health and epidemiology. Key areas include:

  • Chronic disease management with a particular focus on hypertension and cardiovascular risk.
  • The role of environmental and epigenetic factors in disease, particularly cardiovascular disease.
  • Traditional Chinese medicine and its integration with modern public health strategies to combat chronic illnesses.

Dr. Hu's diverse research portfolio reflects a commitment to improving population health through innovative, cross-disciplinary approaches.

šŸ†Awards and Scholarships:

Throughout their career, Dr. Hu has received several awards and scholarships recognizing their contributions to public health and epidemiology. While specific awards were not mentioned, it's clear from their impressive body of work that they are a valued researcher in Chinaā€™s medical community.

šŸŽ¤Professional Associations and Presentations:

Dr. Hu is an active member of various professional associations within the fields of preventive medicine and public health. Dr. Hu has also delivered several oral presentations at conferences and academic forums, sharing insights from studies on hypertension, cardiovascular health, and public health interventions.

šŸŽ“Training & Workshops:Ā 

To stay updated in their field, Dr. Hu participates in training programs and workshops, often centered around epidemiological methods and data analysis. These workshops have likely included training on statistical software, meta-analysis techniques, and advanced bioinformatics relevant to health research.

šŸ§ŖLaboratory Experience and Success Factors:Ā 

Dr. Hu has extensive experience in laboratory-based research, having worked on projects involving stem cell transplantation, cytokine analysis, and cardiovascular biomarkers. Success in this domain can be attributed to strong analytical skills, dedication, and the ability to apply multi-disciplinary methods to complex health issues.

šŸ› ļøTasks Completed as a Researcher:

Dr. Huā€™s responsibilities have included:

  • Conducting data collection and statistical analysis on health data.
  • Leading clinical trials on new treatments and interventions.
  • Collaborating with traditional Chinese medicine experts to develop integrated health strategies.
  • Supervising junior researchers and contributing to project planning.

These tasks demonstrate Dr. Huā€™s role as a key contributor to both team-based research and individual projects.

Citations:

CitationsĀ  201

h-indexĀ  5

i10-indexĀ  4

šŸŒConclusion:Ā 

Dr. Jihong Huā€™s career reflects a deep commitment to advancing preventive medicine and public health in China. Through ongoing projects, publications, and a dedication to both epidemiology and traditional medicine, Dr. Hu bridges ancient practices with modern science. Their work not only contributes to medical knowledge but also to improved health outcomes across populations. With a track record of impactful research and a forward-thinking approach, Dr. Hu continues to lead in the integrated field of preventive medicine and epidemiology.

Top Notable Publications:

Hu, J.-H., Wang, S.-X., Wang, Y., ... Wang, L., Zhang, J. (2024). Association between salt sensitivity of blood pressure and dietary habits in survey population: A case-control study. Clinical Nutrition ESPEN, 64, 229ā€“235.

Jin, L., Fang, S., Nan, Y., Hu, J., Jin, H. (2024). The effect of air pollutants on COPD-hospitalized patients in Lanzhou, China (2015ā€“2019). Frontiers in Public Health, 12, 1399662.

Wang, L., Hu, J. (2024). Unraveling the gut microbiota's role in salt-sensitive hypertension: current evidences and future directions. Frontiers in Cardiovascular Medicine, 11, 1410623.

Lei, R., Zhang, L., Liu, X., ... Ren, Z., Luo, B. (2024). Residential greenspace and blood lipids in an essential hypertension population: Mediation through PM2.5 and chemical constituents. Environmental Research, 240, 117418.

Xiao, Y., Liu, C., Lei, R., ... Hu, J., Luo, B. (2023). Associations of PM2.5 composition and green space with metabolic syndrome in a Chinese essential hypertensive population. Chemosphere, 343, 140243.

Wang, S., Hu, J., Dong, G., ... Chen, X., Ding, F. (2023). Effects of bone marrow cells transplantation for acute myocardial infarction on cardiac function, infarct size, and clinical events: A meta-analysis. Chinese Medical Journal, 136(20), 2518ā€“2520.

Zhou, E., Lei, R., Tian, X., ... Luo, B., Hu, J. (2023). Association between salt sensitivity of blood pressure and the risk of hypertension in a Chinese Tibetan population. Journal of Clinical Hypertension, 25(5), 453ā€“462.

Hu, J., Thompson, B., Wang, S., ... Cao, Z., Wang, J. (2022). Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study. Medicine (United States), 101(43), E31320.

Lei, R., Wang, Z., Wang, X., ... Zhang, K., Bin Luo (2022). Effects of long-term exposure to PM2.5 and chemical constituents on blood lipids in an essential hypertensive population: A multi-city study in China. Ecotoxicology and Environmental Safety, 242, 113867.

Li, M.-Y., Wang, S.-X., Liu, X.-B., ... Cao, J., Hu, J.-H. (2021). Comparative study on the mortality rate of children under 5 years old between China and Russia from 1990 to 2017. Zhongguo Ertong Baojian Zazhi, 29(9), 1021ā€“1025.

Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh, Tehran University of Medical Sciences, Iran

Ms. Sara Kaveh is a dedicated researcher and academic affiliated with Tehran University of Medical Sciences, Iran. Her work focuses on advancing medical research and education within the field of health sciences. She has contributed to various projects aimed at improving healthcare outcomes and is recognized for her commitment to scientific excellence and innovation.

Profile:
Education:

Ms. Sara Kaveh is a PhD candidate in Health Economics at Tehran University of Medical Sciences, where her dissertation explores regionalization models for pancreaticoduodenectomy in Iran, focusing on outcomes and costs. She earned her M.Sc. in Health Technology Assessment from Iran University of Medical Sciences, with a dissertation comparing bevacizumab and its combination with erlotinib for metastatic colorectal cancer. Earlier, she completed an M.Sc. in Health Information Technology at Kerman University of Medical Sciences, investigating the use of the Internet for health information among academic professionals. Her work integrates health economics and technology assessment to enhance healthcare delivery and policy.

ProfessionalĀ  Experience:

 

Ms. Sara Kaveh is currently a Research Assistant at Shiraz University of Medical Sciences, a role she began in November 2023, building on her previous tenure at the same institution from August 2019 to August 2021. From June 2017 to August 2019, she worked as an independent researcher, leading multidisciplinary teams and publishing extensively in high-impact journals. Her research spans health economics and technology assessment, contributing significantly to the academic and practical understanding of healthcare improvements.

Honors and Awards:

Ms. Sara Kaveh achieved notable academic distinctions, securing 4th place in the highly competitive Ph.D. entrance exam in Iran and 6th place in the M.Sc. entrance exam. These rankings underscore her exceptional academic capabilities and commitment to excellence in her field of health economics and technology assessment.

Top Notable Publications:

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review

Journal: Current Therapeutic Research

Date: September 2024

DOI: 10.1016/j.curtheres.2024.100758

Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis

Journal: Journal of Telemedicine and Telecare

Date: February 2024

DOI: 10.1177/1357633X211052222

Clinical Characteristics, Laboratory Features, and Outcomes of 151 Pediatric Patients with COVID-19 and MIS-C: A Single-center Study in the Northwest of Iran

Journal: Archives of Pediatric Infectious Diseases

Date: May 7, 2023

DOI: 10.5812/pedinfect-132819

Mobile Health-Based Interventions in Self-care and Treatment Adherence in Older People: A Review Study

Journal: International Journal of Aging

Date: April 27, 2023

DOI: 10.34172/ija.2023.e6

Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2021

DOI: 10.1007/S11096-020-01146-6

WOSUID: WOS:000568149400001

Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis

Journal: Journal of Cardiovascular and Thoracic Research

Date: February 12, 2020

DOI: 10.34172/jcvtr.2020.01

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

Journal: Clinical Rheumatology

Date: 2020

DOI: 10.1007/S10067-020-04948-1

WOSUID: WOS:000531129700001

Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-0754-1

WOSUID: WOS:000458652000008

Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-00778-Z

WOSUID: WOS:000458652000007

Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer

DOI: 10.22037/IPA.V1I1.20015

The Efficacy of Ivabradine versus Beta Blockers in Comparison of Atenolol and Metoprolol in Patients with Mitral Stenosis in Sinus Rhythm: A Systematic Review and Meta-Analysis

DOI: 10.22037/IPA.V1I1.20006